We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$13B
AUM Growth
+$1.56B
Cap. Flow
+$847M
Cap. Flow %
6.54%
Top 10 Hldgs %
18.23%
Holding
2,527
New
188
Increased
1,360
Reduced
792
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 6.93%
2 Financials 4.91%
3 Healthcare 4.18%
4 Consumer Discretionary 3.53%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHO icon
1151
Invesco Water Resources ETF
PHO
$2.06B
$989K 0.01%
25,593
-316
-1% -$11.7K
KSU
1152
DELISTED
Kansas City Southern
KSU
$987K 0.01%
6,444
+160
+3% +$23.5K
TER icon
1153
Teradyne
TER
$64.2B
$985K 0.01%
14,447
+212
+1% +$13.5K
EXEL icon
1154
Exelixis
EXEL
$12.5B
$983K 0.01%
55,771
+6,545
+13% +$111K
FMHI icon
1155
First Trust Municipal High Income ETF
FMHI
$1.01B
$979K 0.01%
+18,359
New +$977K
IVR icon
1156
Invesco Mortgage Capital
IVR
$805M
$979K 0.01%
5,882
+436
+8% +$69.9K
IEV icon
1157
iShares Europe ETF
IEV
$1.7B
$978K 0.01%
20,823
+12,122
+139% +$545K
PFFD icon
1158
Global X US Preferred ETF
PFFD
$2.18B
$978K 0.01%
39,065
+15,485
+66% +$386K
XSW icon
1159
State Street SPDR S&P Software & Services ETF
XSW
$515M
$976K 0.01%
9,605
+1,903
+25% +$186K
ALXN
1160
DELISTED
Alexion Pharmaceuticals
ALXN
$976K 0.01%
9,028
-310
-3% -$33.2K
OGE icon
1161
OGE Energy
OGE
$9.69B
$973K 0.01%
21,886
+317
+1% +$13.7K
MRVL icon
1162
Marvell Technology
MRVL
$199B
$971K 0.01%
36,545
+13,064
+56% +$331K
WMB icon
1163
Williams Companies
WMB
$90.1B
$970K 0.01%
40,903
+4,236
+12% +$97K
HYZD icon
1164
WisdomTree Trust WisdomTree Interest Rate Hedged High Yield Bond Fund
HYZD
$260M
$968K 0.01%
41,776
-3,610
-8% -$83.1K
UA icon
1165
Under Armour Class C
UA
$2.2B
$966K 0.01%
50,387
-4,014
-7% -$70.6K
LTC
1166
LTC Properties
LTC
$2.1B
$965K 0.01%
21,550
+3,676
+21% +$177K
BTZ icon
1167
BlackRock Credit Allocation Income Trust
BTZ
$956M
$964K 0.01%
68,966
+37,065
+116% +$505K
PHM icon
1168
Pultegroup
PHM
$24.6B
$964K 0.01%
24,846
-514
-2% -$20K
JFR icon
1169
Nuveen Floating Rate Income Fund
JFR
$1.25B
$963K 0.01%
94,002
+13,786
+17% +$132K
RNG icon
1170
RingCentral
RNG
$5.25B
$960K 0.01%
5,694
+1,405
+33% +$232K
BFAM icon
1171
Bright Horizons
BFAM
$3.76B
$957K 0.01%
6,371
-115
-2% -$17.3K
NTR icon
1172
Nutrien
NTR
$32.1B
$957K 0.01%
19,979
-117
-0.6% -$5.65K
FRA icon
1173
BlackRock Floating Rate Income Strategies Fund
FRA
$392M
$956K 0.01%
+71,160
New +$916K
VXX icon
1174
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$142M
$954K 0.01%
986
+446
+83% +$540K
PZA icon
1175
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.27B
$952K 0.01%
35,979
-4,853
-12% -$128K

Similar funds

Cambridge Investment Research Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Cambridge Investment Research Advisors held 2,527 positions worth $13B, up 14% from $11.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors deployed $847M of net new capital in Q4 2019, opening 188 new positions and adding to 1,360 existing holdings. Its largest new stake was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 6.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $23.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2019 buy was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.
  • Cambridge Investment Research Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q4 2019, an estimated $38.2M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2019 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $23.2M.
  • Cambridge Investment Research Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $13.9M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $13B portfolio in Q4 2019.
  • Cambridge Investment Research Advisors opened 188 new positions and closed 124 in Q4 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 14% quarter-over-quarter to $13B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.